HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF- κB activation in Jurkat cells

AIDS Research and Human Retroviruses

Volumn 12, Issue 13, 1996, Pages 1209-1216

  Shatrov, Vladimir A ^a   Ratter, Frank ^a   Gruber, Andreas ^a   Dröge, Wulf ^a   Lehmann, Volker ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; VIRUS GLYCOPROTEIN;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA CELL LINE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VIRUS REPLICATION;

EID: 0029794237     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1209     Document Type: Article

References (37)

1. Zauli G, Davis BR, Re MC, Visani G, Furlini G, and La Placa M: Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: A potential mechanism for HIV-1 induced hematopoietic suppression. Blood 1992;80:3036-3043.
2. Duh EJ, Maury WJ, Folks TM, Fauci AS, and Rabson AB: Tumor necrosis factor α activates HIV type 1 through inductions of nuclear factor binding to NF-κB sites in the long terminal repeat. Proc Natl Acad Sci USA 1989;86:5974-5979.
3. Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, and Fauci AS: Tumor necrosis factor α induces expression of immunodeficiency virus in a chronically infected T cell clone. Proc Natl Acad Sci USA 1989;86:2365-2368.
4. Oakes JW, Bagasra O, Duan L, and Pomerantz RJ: Association of alterations in NF-κB moieties with HIV type 1 proviral latency in certain monocytic cells. AIDS Res Hum Retroviruses 1994;10:1213-1219.
5. Baeuerle PA and Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-179.
6. Thanos D and Maniatis T: NF-κB: A lesson in family values. Cell 1995;80:529-532.
7. Ledbetter JA, June CH, Rabinovitch PS, Grossman A, Tsu TT, and Imboden JB: Singal transduction through CD4 receptors: Stimulatory vs inhibitory activity is regulated by CD4 proximity to the CD3/T cell receptor. Eur J Immunol 1988;18:525-532.
8. Maddon PJ, Dalgleish AG, McDougal JC, Clapham PR, Weiss RA, and Axel R: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47: 333-348.
9. Lasky LA, Nakamura G, Smith DH, Fenie C, Shimasaki C, Patzer E, Berman P, Gregory T, and Capon DJ: Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987;50:975-985.
10. Klatzman D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, and Montagnier L: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (London) 1984;312:767-768.
11. + T cell function by the HIV envelope protein gp120. J Immunol 1988;141:3715-3717.
12. Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, and Bolognesi DP: HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J Immunol 1989;142:3091-3097.
13. Shaw AS, Amrein KE, Hammond C, Stern DF, Sefton BM, and Rose JK: The Lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain. Cell 1989;59:627-636.
14. Cullen BR: The HIV-1 Tat protein: An RNA sequence-specific progressivity factor? Cell 1990;63:655-657.
15. Rosen CA and Pavlakis GN: Tat and Rev: Positive regulators of HIV gene expression. AIDS 1990;4:499-509.
16. Vaishnav YN and Wong-Staal F: The biochemistry of AIDS. Annu Rev Biochem 1991;60:577-630.
17. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, Lowe AD, Singh M, Skimmer MA, and Valerio R: Human immunodeficiency virus 1 Tat protein binds transactivation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci USA 1989;86:6925-6929.
18. Cordingley MG, Lafemina RL, Callahan PL, Condra JH, Sardana VV, Graham DJ, Nguyen TM, Legrow K, Gotlib L, Schlabach AJ, and Colonno RJ: Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. Proc Natl Acad Sci USA 1990;87:8985-8989.
19. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, and Wong-Staal F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (London) 1990;345:84-86.
20. Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R, Gallo RC, and Ensoli B: Effects of the human immunodeficiency virus type-1 Tat protein on the expression of inflammatory cytokines. J Virol 1992;66:7159-7167.
21. Viscidi RP, Mayur K, Lederman HM, and Frankel AD: Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 1989;246:1606-1608.
22. Link R, Li-Weber M, Jäggle C, and Krammer PH: Suppression of interleukin 4 expression by HIV-1 Tat. J Cell Biochem 1992;S16E:37-39.
23. Westendorp MO, Shatrov YA, Schulze-Osthoff K, Frank R, Kraft M, Los M, Krammer PH, Droge W, and Lehmann V: HIV-1 Tat potentiates TNF-induced NF-κB activation and cytotoxicity by altering the cellular redox state. EMBO J 1995;14:546-554.
24. Zabel U, Schreck R, and Baeuerle P: DNA binding of purified transcription factor NF-κB. J Biol Chem 1991;266:252-260.
25. Staal FJT, Roederer M, Herzenberg LA, and Herzenberg LA: Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87:9943-9947.
26. Schulze-Osthoff K, Beyaert R, Vandervoorde V, Haegeman G, and Fiers W: Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene inductive effects of TNF. EMBO J 1993;12:3095-3104.
27. Bergmann S, Shatrov V, Ratter F, Schiemann S, Schulze-Osthoff K, and Lehmann V: Adenosine and homocysteine together enhance TNF-mediated cytotoxicity but do not alter activation of nuclear factor κB. J Immunol 1994;153:1736-1743.
28. Staal FJT, Roederer M, Raju PA, Anderson MT, Ela SW, Herzenberg LA, and Herzenberg LA: Antioxidants inhibit stimulation of HIV transcription. AIDS Res Hum Retroviruses 1993;9:299-306.
29. Anderson MT, Staal FJT, Gitler C, Herzenberg LA, and Herzenberg LA: Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc Natl Acad Sci USA 1994;91:11527-11531.
30. lck activation and TCR desensitization independent of TCR tyrosine phosphorylation. J Immunol 1994;153:2905-2917.
31. lck CD3-T cell receptor interactions and inhibits CD3 signaling. Eur J Immunol 1995;25:1417-1425.
32. Weber JR, Bell GM, Han MY, Pawson T, and Imboden JB: Association of the tyrosine kinase lck with phospholipase C-γl after stimulation of the T cell antigen receptor. J Exp Med 1992;176:373-379.
33. + T cells inhibits the binding activity of NF-AT, NF-κB and AP-1, three nuclear factors regulating interleukin 2 gene enhancer activity. Eur J Immunol 1994;24:2646-2652.
34. lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J 1994;13:774-783.
35. Benkirane M, Jeang K-T, and Devaux Ch: The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells. EMBO J 1994;13:5559-5569.
36. Oh S-Y, Cruikshank WW, Raina J, Blanchard GC, Adler WH, Walker J, and Kornfeld H: Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr 1992;5:251-256.
37. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993;362:355-358.